Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Ophthalmic Drugs Industry?
In recent times, there has been considerable growth in the ophthalmic drugs market. The market, valued at $39.36 billion in 2024, is projected to increase to $42.25 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.3%. This growth during the historic period is associated with various factors such as, rising cases of eye disorders, investments in R&D for eye care, changes in lifestyle, worldwide increase in diabetes cases and government’s vision care initiatives.
Over the next few years, the size of the ophthalmic drugs market is anticipated to experience robust growth, scaling up to “$56.35 billion in 2029 with a compound annual growth rate (CAGR) of 7.5%“. This predicted growth during the forecast period is credited to advancements in biopharmaceutical technology, a surge in the incidence of myopia, a growing elderly population, strategies of personalized medicine, and the legislative backing for infrequent disorders. Key market trends forecasted include the rise of biologics and gene therapies, amplified attention on dry eye therapeutics, progress in glaucoma treatment, the advent of combination therapies, and an emphasis on age-related macular degeneration (AMD).
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10065&type=smp
#Which Factors Are Currently Driving The Growth Of The Ophthalmic Drugs Market?
The heightened occurrence of ophthalmic conditions is anticipated to fuel the expansion of the ophthalmic drug market. Ophthalmic disorders encompass any disease or condition that impacts the eye and its adjunct structures, leading to vision impairment and various eye diseases. Ophthalmic pharmaceuticals are medicinal products utilized for the treatment of these eye conditions. Therefore, the rising prevalence of these disorders amplifies the need for ophthalmic drugs. For instance, the Centers for Disease Control and Prevention (CDC), a US-based government entity, projected that in 2022, 17.2% of Americans aged over 40 – approximately 20.5 million individuals – would be affected by cataracts in at least one eye. Hence, the burgeoning frequency of such ophthalmic disorders is catalyzing the ophthalmic drug market.
The ophthalmic drugs market covered in this report is segmented –
1) By Type: Prescription Drugs, Over-The-Counter Drugs
2) By Class: Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes
3) By Disease: Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases
4) By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems
5) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies
Subsegments:
1) By Prescription Drugs: Antiglaucoma Agents, Anti-inflammatory Drugs, Antibiotics, Antivirals, Corticosteroids, Other Prescription Drugs
2) By Over-The-Counter Drugs: Artificial Tears, Allergy Relief Medications, Redness Relievers, Ocular Vitamins And Supplements, Other OTC Drugs
Which Emerging Trends And Strategic Shifts Are Shaping The Ophthalmic Drugs Market?
One prominent trend escalating in the ophthalmic drug market is product innovation. Big players in this market are concentrating their efforts on creating new solutions to bolster their standing. For instance, in January 2022, Sun Pharmaceutical Canada Inc., renowned for its research and development in innovative dermatology and ophthalmology medicines, introduced an ophthalmic drug named CEQUA (cyclosporine ophthalmic solution 0.09% w/v). This drug, aimed at addressing dry eye disease, was launched in Canada. The drug utilizes nano micellar (NCELL) technology to enhance ocular tissue penetration by augmenting the bioavailability and physicochemical stability of cyclosporine.
Who Are The Main Participants Shaping The Ophthalmic Drugs Market Landscape?
Major companies operating in the ophthalmic drugs market include AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Coherus Biosciences Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Mitotech SA, Akorn Incorporated, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Kala Pharmaceuticals Inc., Aurobindo Pharma Ltd., Eyevance Pharmaceuticals, Acucela Inc., Dompe Farmaceutici S.p.A., Xbrane Biopharma AB, Laboratoires Théa
https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report
Which Region Currently Holds The Largest Share In The Ophthalmic Drugs Market?
North America was the largest region in the ophthalmic drugs market in 2024. The regions covered in the ophthalmic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=10065&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
